CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 17 of 48

Rheumatology (Oxford)

Briefs 641–680 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Physical activity in relation to the risk of systemic lupus erythematosus: a prospective study including 401 745 individuals

    Cohort studyLupus & APS

  2. Rheumatology (Oxford)

    Endothelial cell dysfunction in RA: biomarkers IL-8, E-selectin, VCAM-1 and MCP-1 correlated with PET/CT

    Cohort studyRA

  3. Rheumatology (Oxford)

    Differential impact of immune-mediated inflammatory diseases before versus after cancer on patient survival: a nationwide cohort study

    Cohort studyAcross diseases

  4. Rheumatology (Oxford)

    Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study

    Cohort studyRA

  5. Rheumatology (Oxford)

    Long-term effectiveness and safety of baricitinib treatment on refractory or severe juvenile dermatomyositis

    Cohort studyPediatric

  6. Rheumatology (Oxford)

    Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project

    Guideline or statementMyositis

  7. Rheumatology (Oxford)

    Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study

    Cohort studyVasculitis & PMR

  8. Rheumatology (Oxford)

    Plasma C4d levels correlate with treatment response and renal activity in proliferative lupus nephritis

    Cohort studyLupus & APS

  9. Rheumatology (Oxford)

    Short Form-36 psychometric properties in idiopathic inflammatory myopathies: reliability, validity and responsiveness

    Diagnostic or prognostic studyMyositis

  10. Rheumatology (Oxford)

    Incidence and prevalence of Behçet’s disease in Oslo, Norway: a two-decade population-based analysis

    Cohort studyVasculitis & PMR

  11. Rheumatology (Oxford)

    Indications, efficacy and safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohort

    Cohort studyPediatric

  12. Rheumatology (Oxford)

    Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren’s disease

    Case-control studySjögren's & overlap

  13. Rheumatology (Oxford)

    What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK?

    Research articleSpondyloarthritis & PsA

  14. Rheumatology (Oxford)

    Abatacept for the treatment of myositis-associated interstitial lung disease

    Randomized controlled trialMyositis

  15. Rheumatology (Oxford)

    Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritis

    Mechanistic studyLupus & APS

  16. Rheumatology (Oxford)

    Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren’s syndrome: a Danish cohort study

    Cohort studySjögren's & overlap

  17. Rheumatology (Oxford)

    Diminished SUV3 expression and its functional implications in the IFN-enriched monocyte subset of childhood Sjögren’s disease

    Mechanistic studySjögren's & overlap

  18. Rheumatology (Oxford)

    Recruitment rate comparison between a virtual tele-research cohort and a traditional centre-based cohort in idiopathic inflammatory myopathy

    Cohort studyMyositis

  19. Rheumatology (Oxford)

    Real-world care patterns and specialist encounters of patients with systemic autoimmune rheumatic disease-related interstitial lung disease in the United States: a retrospective administrative claims database analysis

    Cohort studyAcross diseases

  20. Rheumatology (Oxford)

    Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Rasch measurement theory to identify items and domains

    Diagnostic or prognostic studyRA

  21. Rheumatology (Oxford)

    Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal

    Cross-sectional studyPediatric

  22. Rheumatology (Oxford)

    Post-traumatic stress disorder and systemic lupus erythematosus: insights from a systematic review

    Meta-analysisLupus & APS

  23. Rheumatology (Oxford)

    Effectiveness of JAK inhibitors in biologics-naïve patients with RA: a population-based study

    Cohort studyRA

  24. Rheumatology (Oxford)

    Chronic musculoskeletal pain among Ebola survivors in Guinea: a cross-sectional study reveals key risk factors and the need for specialized care

    Cross-sectional studyFibromyalgia & pain

  25. Rheumatology (Oxford)

    T cells of patients with systemic sclerosis or Sjögren’s disease display an aberrant metabolic state and memory phenotype in blood and lungs

    Mechanistic studySystemic sclerosis

  26. Rheumatology (Oxford)

    Unsupervised machine learning identifies distinct SLE patient endotypes with differential response to belimumab

    Secondary analysisLupus & APS

  27. Rheumatology (Oxford)

    Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis

    Cross-sectional studySystemic sclerosis

  28. Rheumatology (Oxford)

    Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics

    Research articleLupus & APS

  29. Rheumatology (Oxford)

    Step-down treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis: a real-life single-centre study

    Cohort studyVasculitis & PMR

  30. Rheumatology (Oxford)

    Histologic predictors of kidney outcomes in LN: re-evaluating the role of segmental glomerulosclerosis in the chronicity index

    Cohort studyLupus & APS

  31. Rheumatology (Oxford)

    Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

    Cohort studyLupus & APS

  32. Rheumatology (Oxford)

    Right atrial reservoir strain as an early predictor of pulmonary hypertension development in systemic sclerosis: a single-centre pilot study

    Cohort studySystemic sclerosis

  33. Rheumatology (Oxford)

    Risk factors for non-response to initial IVIG plus methylprednisolone therapy in children with Kawasaki disease

    Cohort studyPediatric

  34. Rheumatology (Oxford)

    Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre study

    Cohort studyLupus & APS

  35. Rheumatology (Oxford)

    Responsive and monophasic lupus nephritis: prevalence, associations and outcomes

    Cohort studyLupus & APS

  36. Rheumatology (Oxford)

    Risk factors of digital gangrene secondary to systemic lupus erythematosus flare: real-world data from 2014 to 2022

    Case-control studyLupus & APS

  37. Rheumatology (Oxford)

    Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies

    Cohort studyMyositis

  38. Rheumatology (Oxford)

    Dual-energy CT for evaluating bone marrow oedema in RA: an observational single-center study

    Diagnostic or prognostic studyRA

  39. Rheumatology (Oxford)

    Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

    Cohort studyAutoinflammatory & rare

  40. Rheumatology (Oxford)

    Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis — data from a Portuguese registry

    Cohort studySpondyloarthritis & PsA

All 1,905 Briefs in ExploreShowing Briefs 641–680 of 1,905, newest first